| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Neisseria meningitidis IgG Vaccine Response, MAID
Test CodeNMVR
Alias/See Also
LAB11257
CPT Codes
86317 (x4)
Includes
Serotypes A, C, Y, W-135
Preferred Specimen
0.5 mL serum
Minimum Volume
0.3 mL
Transport Temperature
Refrigerated
Specimen Stability
Room temperature: 5 days Refrigerated: 14 days Frozen: 30
days
Methodology
Multi-Analyte Immunodetection (MAID)
This test was developed and its analytical performance
characteristics have been determined by Quest Diagnostics. It has
not been cleared or approved by FDA. This
assay has been validated pursuant to the CLIA regulations and is used for clinical
purposes.
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Tues
Report Available
2-8 days
Reference Range
Serogroup A <4.0 mcg/mL
Serogroup C <5.0 mcg/mL
Serogroup Y <4.0 mcg/mL
Serogroup W-135 <3.0 mcg/mL
Clinical Significance
This assay measures serum IgG antibodies recognizing polysaccharide antigens from the four Neisseria meningitidis serogroups included in the licensed meningococcal vaccine. The meningococcal vaccine response is best evaluated by testing pre-vaccination and post-vaccination samples in parallel. A two-fold or greater increase for at least two serogroups is expected when comparing post-vaccination to pre-vaccination results. N. Meningitidis IgG levels peak approximately one month post-vaccination, but decline markedly by two years.
Performing Laboratory
Quest Diagnostics Infectious Disease, Inc. 33608 Ortega Highway, Bldg B-West Wing San Juan Capistrano, CA 92675-2042
Last Updated: February 20, 2023